Raman Spectroscopy

Raman Spectroscopy is a rapid, non-destructive, and label-free analytical technique that provides molecular-level structural information based on inelastic light scattering. It sensitively detects changes in molecular bonds, crystallinity, polymorphism, and intermolecular interactions, making it a powerful tool for qualitative and quantitative characterization of pharmaceutical materials.

In drug-excipient compatibility studies, Raman analysis focuses on spectral profile deviations between drug-excipient mixtures and pure components. Key indicators of incompatibility include:

• Peak shift, intensity reduction, or disappearance of characteristic API Raman bands.
• Emergence of new Raman peaks, indicating chemical interactions or polymorphic conversion.
• Changes in crystallinity-related band ratios, revealing amorphization or phase separation.
• Variations in molecular vibration patterns, suggesting ionic interactions or complex formation.

Raman spectroscopy enables fast, micro-volume, and solvent-free screening of potential incompatibilities prior to long-term stability studies, greatly improving formulation development efficiency.

Applications in Drug-Excipient Compatibility Studies

Raman spectroscopy is widely used in pharmaceutical preformulation and formulation development to identify physical and chemical incompatibilities that affect drug stability, bioavailability, and product performance.

• Rapid Compatibility Assessment: Identifies API-excipient interactions through characteristic Raman peak changes, providing early risk warnings in compliance with FDA and ICH guidelines.
• Polymorph & Salt Screening: Distinguishes crystal forms, solvates, and amorphous states without sample pretreatment.
• Solid Dispersion Characterization: Evaluates drug-polymer miscibility, crystallinity, and phase separation in amorphous formulations.
• Crystallinity Monitoring: Quantifies crystalline–amorphous ratios and detects recrystallization in formulations.
• Moisture & Stress Compatibility: Detects interactions under thermal or humidity stress without complex sample preparation.

Raman requires minimal or no sample preparation, works for solids, liquids, and powders, and enables rapid, non-destructive testing. It can be combined with microscopy (Raman imaging) for spatial distribution analysis, providing comprehensive evidence for regulatory submissions.

PharmaAnalytica's Technology Platform

PharmaAnalytica's Raman-Based Drug-Excipient Compatibility Studies

PharmaAnalytica's Raman services deliver a fast, non-destructive, and molecular-level solution for drug-excipient compatibility evaluation.

High-Throughput Rapid Screening

Automated Raman systems and spectral analysis algorithms enable high-efficiency screening of excipient libraries with automatic peak comparison and compatibility risk marking.

Customized Study Designs

Tailored protocols include polymorph monitoring, crystallinity quantification, humidity/thermal stress testing, and confocal Raman imaging.

Regulatory-Ready Data Packages

Reports comply with ICH Q1A, Q6A, and USP guidelines, including full spectral data, peak annotations, crystallinity analysis, and compatibility risk ratings (low/medium/high).

End-to-End Expert Support

PhD-level scientists provide pre-study consultation, method optimization, spectral interpretation, and formulation improvement recommendations.

Supported by advanced instruments, professional analytical expertise, and standardized processes, we help clients reduce formulation risks and accelerate pharmaceutical development.